WHOLE SHINE MEDICAL Faces Resumption of Enforcement of 362 Million RMB

Source: China's Enforcement Information Disclosure Network

DentalGoodNews｜According to the China Execution Information Disclosure Platform, the Shanghai Financial Court initiated a resumption of enforcement proceedings against WHOLE SHINE MEDICAL TECHNOLOGY CO.,LTD. (hereinafter referred to as "WHOLE SHINE MEDICAL"), Yin Mou, and Zuo Mou on June 5, 2026, under case number (2026) Shanghai 74 Enforcement Resumption No. 43, with an execution target of approximately 362 million yuan.

This judicial development is compounded by multiple pre-existing risk factors. According to the company's 2025 annual report disclosures and the "Special Explanation on Issuing a Qualified Audit Opinion on the 2025 Financial Statements of WHOLE SHINE MEDICAL TECHNOLOGY CO.,LTD.," the auditing firm Zhonghua Certified Public Accountants (Special General Partnership) issued a qualified audit opinion on the company's 2025 financial statements.

The core of the qualified opinion pertains to WHOLE SHINE MEDICAL's equity investment in Fushun Bank Co., Ltd. (hereinafter referred to as "Fushun Bank"), representing a 6.68% stake. As the auditor was unable to obtain sufficient audit evidence regarding the equity method adjustments and impairment provisions for this asset, with a book value of 431 million yuan, the auditing firm stated it could not determine whether adjustments to the relevant amounts were necessary, nor could it ascertain the potential impact of this matter on the company's profit or loss nature.

In terms of core Oral business, the 51% equity stake in Guangdong Delun Medical Group Co., Ltd. (hereinafter referred to as "Delun Medical") held by WHOLE SHINE MEDICAL's wholly-owned subsidiary Zhiyu Medical Investment Co., Ltd. was ordered to be frozen by the People's Court of Chuanying District, Jilin City, in October 2025, with a freeze period of two years. According to a previous report by DGN (April 29, 2026), as a core holding subsidiary, Delun Medical achieved an operating revenue of 638 million yuan in 2025, a year-on-year decrease of approximately 17.57%; its net profit for the period was -17.6013 million yuan, turning from a profit of 45.8228 million yuan in the previous period to a loss.

As of the publication of this article, WHOLE SHINE MEDICAL has disclosed certain matters in relevant announcements. The company's subsequent progress shall be subject to official announcements.